Mon panier

Cynomolgus GPRC5D Protein, Flag,His Tag (Detergent) (SPR verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
GPD-C52D3-20ug
$805.00
GPD-C52D3-100ug
$2985.00
GPD-C52D3-500ug
$7480.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    GPRC5D, G-protein coupled receptor family C group 5 member D

  • Source

    Detergent Cynomolgus GPRC5D, Flag,His Tag (GPD-C52D3) is expressed from human 293 cells (HEK293). It contains AA Tyr 2 - Phe 192 & Glu 197 - Leu 262 (Accession # A0A2K5W6I7-1).

    Predicted N-terminus: Asp

    Request for sequence
  • Molecular Characterization

    GPRC5D Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a flag tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 51.9 kDa. The protein migrates as 35-40 kDa under reducing (R) condition (SDS-PAGE).

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >80% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    GPRC5D SDS-PAGE

    Cynomolgus GPRC5D, Flag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 80%.

  • Bioactivity-SPR

     GPRC5D SPR

    Anti-GPRC5D Antibody immobilized on CM5 Chip can bind Cynomolgus GPRC5D, Flag,His Tag (Cat. No. GPD-C52D3) with an affinity constant of 0.122 μM as determined in a SPR assay (Biacore T200) (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

An orphan G protein-coupled receptor with highly restricted expression in malignant plasma cells and hard keratinized tissues (hair/nail). This profile mitigates off-tumor toxicity, establishing GPRC5D as a breakthrough target for bispecific antibodies and CAR-T therapies in relapsed/refractory multiple myeloma.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    G-protein coupled receptor family C group 5member D

  • Catégorie:

  • Nombre de médicaments répertoriés:

    1 Détails

  • Nombre de médicaments cliniques:

    38 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte